Donna Angotti, MD
Surgery · Doylestown, PANPI 1366499345
Payments from drug & device makers
Across 93 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$363
- CSL Behring$191
- Bristol Myers Squibb$110
- Incyte Corporation$90
- Merck$83
- Takeda Pharmaceuticals U.S.A., Inc.$77
- plus $1K from 33 others
What the payments were for
- Food & beverage$1,962100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 16 | $363 |
| CSL Behring | 9 | $191 |
| Bristol Myers Squibb | 6 | $110 |
| Incyte Corporation | 4 | $90 |
| Merck | 5 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| Eisai Inc. | 3 | $61 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Bayer | 3 | $59 |
| Genmab U.S., Inc. | 2 | $52 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Smith+Nephew | 3 | $50 |
| EMD Serono, Inc. | 1 | $49 |
| Acadia Pharmaceuticals Inc | 2 | $49 |
| Seagen Inc. | 3 | $44 |
| MDD US Operations, LLC | 1 | $38 |
| Mirati Therapeutics, Inc. | 2 | $37 |
| Tesaro, Inc. | 2 | $37 |
| Tactile Systems Technology Inc | 2 | $36 |
| Merz North America, Inc. | 1 | $36 |
| UCB, Inc. | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Pfizer | 1 | $26 |
| Sobi, Inc | 1 | $26 |
| Astellas Pharma US Inc | 1 | $22 |
| Davol Inc. | 1 | $22 |
| Acorda Therapeutics, Inc | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $20 |
| Aquestive Therapeutics, Inc. | 1 | $19 |
| Amgen | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| Tanabe Pharma America, Inc. | 1 | $18 |
| Medtronic | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| KCI USA, Inc. | 1 | $16 |
| Merit Medical Systems Inc | 1 | $16 |
| Focal Therapeutics, Inc. | 1 | $16 |
| Livanova USA, Inc. | 1 | $15 |
How this compares
$1,962 in reported general payments places this provider in the 55th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $229 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $178 |
Paid to pharmacies, not to this prescriber.
Other surgery in Doylestown
- Giorgos KarakousisPhiladelphia$8.8M
- James MarkmannPhiladelphia$1.8M
- John MiuraPhiladelphia$1.3M
- Martin WijkstromPittsburgh$1.3M
- Andy KiserPittsburgh$1.1M
- Blair JobePittsburgh$827K
- Glenn SteeleDanville$698K
- Olwadamilola FayanjuPhiladelphia$668K
- Maher El ChaarAllentown$667K
- George EidPittsburgh$623K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.